(Total Views: 1246)
Posted On: 08/30/2020 9:14:29 PM
Post# of 153903
Creatv partnered with CYDY to use LifeTracDx in two cancer trials
The Creatv press release is here:
https://creatvbio.com/s/CMT_ImmuneCells.pdf
Interesting to note that Massimo Cristofanilli has been mentioned in a CC end July 2020 and was working on the CYDY trials in 2018, see:
https://www.cytodyn.com/newsroom/press-releas...e-negative
Text from the press release that mentions the CYDY relationship:
In addition to the government trials, Creatv is implementing LifeTracDx in more than 20 clinical trials —from basic research to drug development —with biopharmaceutical firm such as BriaCell, where it is aiding in development of cancer vaccines. Creatv has also partnered with CytoDyn in two clinical trials using the firm's drug that targets the CCR5 cancer gene.
The Creatv press release is here:
https://creatvbio.com/s/CMT_ImmuneCells.pdf
Interesting to note that Massimo Cristofanilli has been mentioned in a CC end July 2020 and was working on the CYDY trials in 2018, see:
https://www.cytodyn.com/newsroom/press-releas...e-negative
Text from the press release that mentions the CYDY relationship:
In addition to the government trials, Creatv is implementing LifeTracDx in more than 20 clinical trials —from basic research to drug development —with biopharmaceutical firm such as BriaCell, where it is aiding in development of cancer vaccines. Creatv has also partnered with CytoDyn in two clinical trials using the firm's drug that targets the CCR5 cancer gene.
(8)
(0)
